DUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 and is projected to reach US$27.5 Billion by 2030, growing at a CAGR of 5.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the constipation treatment market is driven by several factors, including the increasing prevalence of gastrointestinal disorders, the growing aging population, and the rise in demand for OTC medications. The expanding awareness of digestive health and the rising trend toward self-medication are also boosting the demand for natural and OTC treatment options.
Pharmaceutical advancements, such as the development of novel drugs with fewer side effects and more targeted action, are further contributing to market growth. Additionally, the increasing focus on preventive healthcare and lifestyle management is driving the adoption of dietary supplements and probiotics.
Report Scope
The report analyzes the Constipation Treatment market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.
- Segments: Disease Type (Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome with Constipation (IBS-C), Opioid-Induced Constipation (OIC)); Therapeutic Option (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C Agonists, 5-HT4 Receptor Agonists).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Laxatives segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 6.4%. The Chloride Channel Activators segment is also set to grow at 4.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $5.1 Billion in 2024, and China, forecasted to grow at an impressive 8.9% CAGR to reach $6.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott, AbbVie’s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 41 companies featured in this Constipation Treatment market report include:
- Abbott
- AbbVie
- Albireo Pharma
- AstraZeneca
- Bausch Health Companies
- Bayer
- Cosmo Pharma
- Daewoong
- Ironwood Pharmaceuticals
- Janssen Pharmaceutical
- Mallinckrodt
- Prestige Brands
- Renexxion
- Sanofi
- Shionogi
- Takeda Pharmaceutical Co.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $19.5 Billion |
| Forecasted Market Value (USD) by 2030 | $27.5 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
MARKET OVERVIEW
- Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
- How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
- Constipation Treatment – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Growing Prevalence of Gastrointestinal Disorders
- Increasing Demand for Over-the-counter Laxatives and Natural Remedies
- Technological Advancements in Prescription Medications
- Rising Use of Probiotics and Fiber Supplements in Constipation Management
- Expanding Geriatric Population Driving Demand for Treatment Solutions
- Growing Awareness of Digestive Health and Preventive Care
- Increased Adoption of Combination Therapies for Chronic Conditions
- Rise in Demand for Home-based Constipation Treatment Products
- Rising Focus on Gut Health and Holistic Treatment Approaches
- Growing Popularity of Personalized Medicine in Constipation Treatment
For more information about this report visit https://www.researchandmarkets.com/r/spb1df
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900